76491202
Feb 19, 2003
Aug 30, 2005
PHARMATHENE CANADA INC.
Subscribe
Recombinant proteins in the form of biomaterials for use in the manufacture of pharmaceuticals for the prevention, treatment and detection of toxic effects of nerve agents and other chemicals